Characterization of small spheres derived from various solid tumor cell lines: Are they suitable targets for T cells?

Clinical and Experimental Metastasis

Volumn 30, Issue 6, 2013, Pages 781-791

  Busse, Antonia ^a   Letsch, Anne ^a   Fusi, Alberto ^a   Nonnenmacher, Anika ^a   Stather, David ^a   Ochsenreither, Sebastian ^a   Regenbrecht, Christian Ra ^a   Keilholz, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer stem cells; HLA; Immune escape; Micrometastasis; Tumor antigens; Tumor sphere cells

Indexed keywords

BETA 2 MICROGLOBULIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3BETA; HLA ANTIGEN; MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; NOTCH2 RECEPTOR; PORPHOBILINOGEN DEAMINASE; PROTEASOME; TRANSCRIPTION FACTOR PAX2; TUMOR ANTIGEN; WT1 PROTEIN;

ADHERENT CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER STEM CELL; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CULTURE MEDIUM; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE EVASION; IN VITRO STUDY; MICROMETASTASIS; MOLECULARLY TARGETED THERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; T LYMPHOCYTE; TUMOR CELL LINE; UPREGULATION;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL PROLIFERATION; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; NEOPLASMS; NEOPLASTIC STEM CELLS; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 84887082193     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9578-5     Document Type: Article

References (53)

1. Chaudhuri D, Suriano R, Mittelman A, Tiwari RK (2009) Targeting the immune system in cancer. Curr Pharm Biotechnol 10(2):166-184
2. van der Bruggen P, Van den Eynde BJ (2006) Processing and presentation of tumor antigens and vaccination strategies. Curr Opin Immunol 18(1):98-104
3. Asemissen AM, Brossart P (2009) Vaccination strategies in patients with renal cell carcinoma. Cancer Immunol Immunother 58(7):1169-1174
4. Grange JM, Krone B, Stanford JL (2009) Immunotherapy for malignant melanoma-tracing Ariadne's thread through the labyrinth. Eur J Cancer 45(13):2266-2273
5. Jandus C, Speiser D, Romero P (2009) Recent advances and hurdles in melanoma immunotherapy. Pigment Cell Melanoma Res 22(6):711-723
6. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA (2010) Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 148(1):3-15
7. Feder-Mengus C, Ghosh S, Reschner A, Martin I, Spagnoli GC (2008) New dimensions in tumor immunology: what does 3D culture reveal? Trends Mol Med 14(8):333-340
8. Frank NY, Schatton T, Frank MH (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120(1):41-50
9. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110
10. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH (2008) Identification of cells initiating human melanomas. Nature 451(7176):345-349
11. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-737
12. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111
13. Welte Y, Adjaye J, Lehrach HR, Regenbrecht CR (2010) Cancer stem cells in solid tumors: elusive or illusive? Cell Commun Signal 8(1):6
14. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111-115
15. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells-perspectives on current status and future directions: aACR Workshop on cancer stem cells. Cancer Res 66(19):9339-9344
16. Seliger B (2005) Strategies of tumor immune evasion. BioDrugs 19(6):347-354
17. Kim R, Emi M, Tanabe K (2007) Cancer immunoediting from immune surveillance to immune escape. Immunology 121(1):1-14
18. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240(4849):177-184
19. Desoize B, Jardillier J (2000) Multicellular resistance: a paradigm for clinical resistance? Crit Rev Oncol Hematol 36(2-3):193-207
20. Nederman T (1984) Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. Cancer Res 44(1):254-258
21. Santini MT, Rainaldi G, Indovina PL (2000) Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol 36(2-3):75-87
22. Ghosh S, Rosenthal R, Zajac P, Weber WP, Oertli D, Heberer M, Martin I, Spagnoli GC, Reschner A (2005) Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen. Ann Surg 242(6):851-857 discussion 858
23. Dangles-Marie V, Richon S, El-Behi M, Echchakir H, Dorothee G, Thiery J, Validire P, Vergnon I, Menez J, Ladjimi M, Chouaib S, Bellet D, Mami-Chouaib F (2003) A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down-regulation. Cancer Res 63(13):3682-3687
24. Dangles V, Validire P, Wertheimer M, Richon S, Bovin C, Zeliszewski D, Vallancien G, Bellet D (2002) Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation. Int J Cancer 98(1):51-56
25. Feder-Mengus C, Ghosh S, Weber WP, Wyler S, Zajac P, Terracciano L, Oertli D, Heberer M, Martin I, Spagnoli GC, Reschner A (2007) Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes. Br J Cancer 96(7):1072-1082
26. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20):9328-9337
27. Schatton T, Frank MH (2009) Antitumor immunity and cancer stem cells. Ann N Y Acad Sci 1176:154-169
28. Gedye C, Quirk J, Browning J, Svobodova S, John T, Sluka P, Dunbar PR, Corbeil D, Cebon J, Davis ID (2009) Cancer/testis antigens can be immunological targets in clonogenic CD133 + melanoma cells. Cancer Immunol Immunother 58(10):1635-1646
29. Sigalotti L, Covre A, Zabierowski S, Himes B, Colizzi F, Natali PG, Herlyn M, Maio M (2008) Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status. J Cell Physiol 215(2):287-291
30. Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih CC, Badie B, Hudecek M, Riddell SR, Jensen MC (2009) Recognition and killing of brain tumor stem-like initiating cells by CD8 + cytolytic T cells. Cancer Res 69(23):8886-8893
31. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, Caldera V, Nava S, Ravanini M, Facchetti F, Bruzzone MG, Finocchiaro G (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66(21):10247-10252
32. Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS (2009) Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27(8):1734-1740
33. Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R, Bellora F, Moretta L, Moretta A, Corte G, Bottino C (2009) NK cells recognize and kill human glioblastoma cells with stem cell-like properties. J Immunol 182(6):3530-3539
34. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391-403
35. Busse A, Kraus M, Na IK, Rietz A, Scheibenbogen C, Driessen C, Blau IW, Thiel E, Keilholz U (2008) Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer 112(3):659-670
36. Gorlach A, Acker H (1994) pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells. Biochim Biophys Acta 1227(3):105-112
37. Chignola R, Schenetti A, Andrighetto G, Chiesa E, Foroni R, Sartoris S, Tridente G, Liberati D (2000) Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. Cell Prolif 33(4):219-229
38. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR (2003) Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22(39):7989-7997
39. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T (1996) Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87(7):2878-2884
40. Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ (1996) A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12(5):1005-1014
41. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454(7200):49-55
42. Durda PJ, Dunn IS, Rose LB, Butera D, Benson EM, Pandolfi F, Kurnick JT (2003) Induction of antigen silencing in melanomas by oncostatin M: down-modulation of melanocyte antigen expression. Mol Cancer Res 1(6):411-419
43. Menssen HD, Bertelmann E, Bartelt S, Schmidt RA, Pecher G, Schramm K, Thiel E (2000) Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens. J Cancer Res Clin Oncol 126(4):226-232
44. Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, Mortini P, Ferrone S, Doglioni C, Marincola FM, Galli R, Parmiani G, Maccalli C (2010) Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res 16(3):800-813. doi: 10.1158/1078-0432. CCR-09-2730
45. Guillaume B, Chapiro J, Stroobant V, Colau D, Van Holle B, Parvizi G, Bousquet-Dubouch MP, Theate I, Parmentier N, Van den Eynde BJ (2010) Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc Natl Acad Sci USA 107(43):18599-18604
46. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP (1995) Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 181(4):1459-1471
47. Blair A, Hogge DE, Sutherland HJ (1998) Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR. Blood 92(11):4325-4335
48. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11):2739-2749
49. Le Blanc K, Ringden O (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11(5):321-334
50. Campoli M, Ferrone S (2008) HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27(45):5869-5885
51. Liu Y, Zhao JJ, Wang CM, Li MY, Han P, Wang L, Cheng YQ, Zoulim F, Ma X, Xu DP (2009) Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin Med J 122(1):10-14
52. Castelli EC, Moreau P, Oya e Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L, Giuliatti S, Carosella ED, Donadi EA (2009) In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes. Hum Immunol 70(12):1020-1025
53. Stone JD, Aggen DH, Schietinger A, Schreiber H, Kranz DM (2012) A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell engagers (BiTEs). Oncoimmunology 1(6):863-873